Glioblastoma (GBM) cells that adapt to the in vivo microenvironment often display enhanced invasion driven by EGFR-ERK signaling and epithelial-mesenchymal transition (EMT). This study aimed to characterize an EGFR-ERK-dependent T98G subline (T98G-xeno) and to determine how gallic acid (GA) modulates reactive oxygen species (ROS), EGFR-ERK signaling, EMT and migration. Parental T98G and T98G-xeno cells were compared for proliferation, EMT markers and migration. GA cytotoxicity, ROS, EGFR-ERK signaling and migration were assessed after GA, EGF, N-acetyl-L-cysteine (NAC) or EGFR siRNA treatment. T98G-xeno cells showed faster growth, increased migration, higher levels of mesenchymal markers, and elevated basal p-EGFR/p-ERK ratio versus T98G cells. Non-apoptotic GA increased ROS, decreased p-EGFR/EGFR and p-ERK/ERK ratios, restored E-cadherin/ZO-1, reduced N-cadherin/vimentin and inhibited wound closure and migration. EGF-induced EGFR-ERK activation and migration were antagonized by GA. EGFR siRNA mimicked GA, whereas NAC attenuated GA-induced ROS and partially rescued these effects. GA targets a ROS-EGFR-ERK-EMT axis in T98G-xeno cells, acting as a non-cytotoxic modulator that reverses EMT and limits migration. These findings suggest that GA-based strategies may help restrain invasion in EGFR-ERK-addicted, EMT-enriched GBM.
Background and Objectives: Pediatric traumatic brain injury (pTBI) remains a major pediatric public health problem, despite well-developed injury prevention programs. The purpose of this study is to analyze the emergency surgical outcomes of pTBI in a single institute ten-year retrospective study to offer a real-world clinical result. Materials and Methods: Our institute presented a clinical retrospective, single-institute research study of 150 pediatric TBI cases that were diagnosed and underwent emergency surgical treatment from 2010 to 2019. Results: The incidence of radiological findings is detailed as follows: brain edema (30%, 45/150), followed by acute subdural hematoma (27.3%, 41/150), epidural hematoma (21.3%, 32/150), chronic subdural hemorrhage (10%, 15/150), skull fracture (6.7%, 10/150), and traumatic subarachnoid hemorrhage (4.7%, 7/150). Surgical intervention data revealed that decompressive craniectomy was still the main effective surgical method. The results showed longer hospital stays and higher morbidity rates in the brain edema, acute subdural hematoma, and chronic subdural hemorrhage groups, which were viewed as poor surgical outcome groups. Epidural hematoma, skull fracture and traumatic subarachnoid hemorrhage were categorized into good surgical outcome groups. Notably, the data revealed gross improvement in Glasgow Coma Scale/Score (GCS) evolution after surgical interventions, and the time to cranioplasty was a significant factor in the development of post-traumatic hydrocephalus (PTH). Conclusions: Our study provided real-world data for the distribution of etiology in pTBI and also categorized it into six groups, indicating disease-orientated treatment. In addition, our data supported that decompressive craniectomy (DC) remains a mainstay surgical treatment in pTBI and early cranioplasty could decrease the incidence of PTH.